Studies Conducted at Nihon University School of Medicine on Bacillus Calmette-Guerin Vaccines Recently Published (The Induction of Antigen 85B-Specific CD8+ T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice).

Keywords: BCG Therapy; BCG Vaccines; Bacillus Calmette-Guerin (BCG); Bacillus Calmette-Guerin Vaccines; Bacterial Vaccines; Biological Factors; Biological Products; CD Antigens; CD8 Antigens; Genetics; Health and Medicine; Immunization; Immunization and Public Health; Immunology; Public Health; T-Lymphocyte Antigens; Tuberculosis Vaccines; Vaccination; Vaccines EN BCG Therapy BCG Vaccines Bacillus Calmette-Guerin (BCG) Bacillus Calmette-Guerin Vaccines Bacterial Vaccines Biological Factors Biological Products CD Antigens CD8 Antigens Genetics Health and Medicine Immunization Immunization and Public Health Immunology Public Health T-Lymphocyte Antigens Tuberculosis Vaccines Vaccination Vaccines 2023 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Fresh data on bacillus Calmette-Guerin vaccines are presented in a new report. Studies Conducted at Nihon University School of Medicine on Bacillus Calmette-Guerin Vaccines Recently Published (The Induction of Antigen 85B-Specific CD8[sup +] T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice) Although the Bacillus Calmette-Guerin (BCG) vaccine is the most widely used vaccination for preventing tuberculosis (TB), its efficacy is limited.". [Extracted from the article]